| RS2148183874 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2148184028 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148184058 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148184147 |
DMD
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2148184336 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2148184355 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148184404 |
ALPL
|
Health Risk |
Pathogenic |
Hypophosphatasia, Adult hypophosphatasia |
| RS2148184407 |
DNASE1L1;LOC130068869;TAFAZZIN
|
Health Risk |
Pathogenic |
— |
| RS2148184506 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148184571 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2148184732 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148184736 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS2148184754 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS2148184880 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adult hypophosphatasia, Adult hypophosphatasia |
| RS2148185111 |
TAFAZZIN
|
Health Risk |
Pathogenic/Likely pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS2148185606 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148186224 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS2148186695 |
TAFAZZIN
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS2148189619 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148189653 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148189993 |
SLC9A6
|
Health Risk |
Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2148190013 |
SLC9A6
|
Health Risk |
Pathogenic/Likely pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2148190075 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS2148190118 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2148191858 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS2148192290 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148192392 |
POMGNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148192403 |
ALPL
|
Health Risk |
Pathogenic |
Hypophosphatasia, Adult hypophosphatasia |
| RS2148192417 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, Osteogenesis imperfecta |
| RS2148192444 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Adult hypophosphatasia |
| RS2148192455 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS2148192467 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148192552 |
ALPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Adult hypophosphatasia, Hypophosphatasia |
| RS2148192656 |
ALPL
|
Health Risk |
Pathogenic |
— |
| RS2148192725 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148193045 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148193225 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2148193545 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2148193752 |
KDM6A
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2148193855 |
KDM6A
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2148194212 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2148194520 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148194576 |
TAFAZZIN
|
Health Risk |
Likely pathogenic |
— |
| RS2148194615 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS2148194744 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148194946 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Hypophosphatasia |
| RS2148195004 |
ALPL
|
Health Risk |
Likely pathogenic |
Hypophosphatasia, Adult hypophosphatasia |
| RS2148196270 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148201789 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS2148204773 |
PKLR
|
Health Risk |
Likely pathogenic |
— |
| RS2148204914 |
PKLR
|
Health Risk |
Likely pathogenic |
Pyruvate kinase deficiency of red cells, Pyruvate kinase deficiency of red cells |
| RS2148205473 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148208099 |
PKLR
|
Health Risk |
Pathogenic |
— |
| RS2148208689 |
STAG2
|
Health Risk |
Likely pathogenic |
— |
| RS2148209339 |
STAG2
|
Health Risk |
Pathogenic |
Holoprosencephaly 13, X-linked |
| RS2148211636 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS2148212111 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148212610 |
TAFAZZIN
|
Health Risk |
Pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS2148215487 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neuroblastoma |
| RS2148215943 |
MPV17;UCN
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), MPV17-related disorder |
| RS2148216335 |
MPV17
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, axonal |
| RS2148216461 |
MPV17
|
Health Risk |
Likely pathogenic |
— |
| RS2148217590 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 |
| RS2148218654 |
POMGNT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148218886 |
PKLR
|
Health Risk |
Likely pathogenic |
Pyruvate kinase deficiency of red cells, Pyruvate kinase deficiency of red cells |
| RS2148221101 |
PKLR
|
Health Risk |
Pathogenic |
Pyruvate kinase deficiency of red cells, Pyruvate kinase deficiency of red cells |
| RS2148221946 |
ATP6AP1
|
Health Risk |
Likely pathogenic |
Immunodeficiency 47, Immunodeficiency 47 |
| RS2148221993 |
ATP6AP1
|
Health Risk |
Likely pathogenic |
— |
| RS2148222516 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2148222613 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS2148223097 |
ATP6AP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 47, Immunodeficiency 47 |
| RS2148224789 |
ATP6AP1
|
Health Risk |
Likely pathogenic |
— |
| RS2148225515 |
MPV17
|
Health Risk |
Pathogenic |
— |
| RS2148225587 |
NBAS
|
Health Risk |
Pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS2148226455 |
GDI1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 41 |
| RS2148227605 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS2148228335 |
GDI1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked 41 |
| RS2148233321 |
NBAS
|
Health Risk |
Pathogenic |
Infantile liver failure syndrome 2, Infantile liver failure syndrome 2 |
| RS2148238576 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2148244740 |
ADGRG1
|
Health Risk |
Pathogenic |
— |
| RS2148246019 |
KIDINS220
|
Health Risk |
Pathogenic |
Ventriculomegaly and arthrogryposis, Ventriculomegaly and arthrogryposis |
| RS2148250838 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148257968 |
AHDC1
|
Health Risk |
Likely pathogenic |
— |
| RS2148258030 |
AHDC1
|
Health Risk |
Pathogenic |
— |
| RS2148258069 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2148258238 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2148259374 |
ATRX
|
Health Risk |
Likely pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2148259855 |
ATRX
|
Health Risk |
Likely pathogenic |
— |
| RS2148260344 |
ATRX
|
Health Risk |
Likely pathogenic |
ATRX-related disorder, ATRX-related disorder |
| RS2148260943 |
ATRX
|
Health Risk |
Likely pathogenic |
Intellectual disability-hypotonic facies syndrome, X-linked |
| RS2148261114 |
ATRX
|
Health Risk |
Pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2148263577 |
AHDC1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2148263628 |
AHDC1
|
Health Risk |
Likely pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2148264796 |
ITSN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autistic behavior, Autistic behavior |
| RS2148265222 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2148265469 |
AHDC1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2148266336 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS2148269372 |
AGBL5
|
Health Risk |
Pathogenic |
— |
| RS2148270367 |
ATRX
|
Health Risk |
Likely pathogenic |
— |
| RS2148272898 |
AHDC1
|
Health Risk |
Pathogenic |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |